Literature DB >> 22498120

Intravenous immunoglobulins as treatment of severe cutaneous polyarteritis nodosa.

I Marie1, S Miranda, N Girszyn, J-C Soubrane, T Vandhuick, H Levesque.   

Abstract

We describe three patients with severe refractory cutaneous polyarteritis nodosa, resulting in painful ulcers involving the lower limbs and causing toe necrosis. Due to the severity of the cutaneous manifestations, the three patients received intravenous immunoglobulins at a dose of 1 g/kg/day for 2 days monthly. After the second intravenous immunoglobulin infusion, skin signs dramatically improved and completely healed after the third intravenous immunoglobulin infusion. Our findings indicate that intravenous immunoglobulins can be included in a therapeutic strategy to treat refractory cutaneous polyarteritis nodosa.
© 2012 The Authors. Internal Medicine Journal © 2012 Royal Australasian College of Physicians.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22498120     DOI: 10.1111/j.1445-5994.2012.02739.x

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  1 in total

Review 1.  Cutaneous polyarteritis nodosa successfully treated with topical diflucortolone valerate: a case report & review of the literature.

Authors:  Ruby Haviv; Maya Capua; Jacob Amir; Liora Harel
Journal:  Pediatr Rheumatol Online J       Date:  2014-10-10       Impact factor: 3.054

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.